EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Advances in the natural α‐glucosidase inhibitors

Didem Şöhretoğlu, Gülin Renda, Randolph Arroo, Jianbo Xiao, Suat Sari

eFood · 2023-10 · 4 (5)

DOI: 10.1002/efd2.112 ↗

At a glance

Journal article in eFood, published online on 2023-09-12. Written by Didem Şöhretoğlu and 4 co-authors. Cited 35 times so far (Crossref); 107 references. The full text is freely available (open access, CC BY 4.0).

AstrattDettalji biblijografiċiCiteRelated studies

Abstract (original language)

α‐Glucosidase (AG) inhibitors, one of the classes of oral antidiabetics used to treat type 2 diabetes mellitus, delay digestion and absorption of glucose, which in turn, has a lowering effect on postprandial blood glucose and insulin levels. Natural products are a great source for the development of new AG inhibitory drug candidates. We aim to summarize advances in natural AG inhibitors according to their secondary metabolite groups in the last decade. Their mechanisms of action and structure–activity relationships will especially be discussed.

Cite

APA

Şöhretoğlu, D., Renda, G., Arroo, R., Xiao, J., & Sari, S. (2023). Advances in the natural α‐glucosidase inhibitors. eFood, 4(5). https://doi.org/10.1002/efd2.112

Vancouver

Şöhretoğlu D, Renda G, Arroo R, Xiao J, Sari S. Advances in the natural α‐glucosidase inhibitors. eFood. 2023;4(5). doi:10.1002/efd2.112

BibTeX
@article{hretolu2023,
  author = {Şöhretoğlu, Didem and Renda, Gülin and Arroo, Randolph and Xiao, Jianbo and Sari, Suat},
  title = {Advances in the natural α‐glucosidase inhibitors},
  journal = {eFood},
  year = {2023},
  volume = {4},
  number = {5},
  doi = {10.1002/efd2.112}
}
Start for free →